Share Price and Basic Stock Data
Last Updated: January 24, 2026, 3:36 pm
| PEG Ratio | 0.73 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Akzo Nobel India Ltd, a prominent player in the paints and varnishes industry, reported a share price of ₹2,954 and a market capitalization of ₹13,451 Cr. The company has demonstrated a strong revenue growth trajectory, with sales recorded at ₹3,802 Cr for the fiscal year ending March 2023, rising to ₹4,091 Cr for the fiscal year 2025. The quarterly sales figures also reveal a consistent upward trend, peaking at ₹1,036 Cr in June 2024, with subsequent quarters maintaining robust performance. Notably, the trailing twelve months (TTM) revenue stood at ₹3,903 Cr, indicating stability and a solid foundation for future growth. The company’s operational efficiency, reflected in its operating profit margin (OPM) of 16%, remains competitive within the sector, positioning Akzo Nobel favorably against industry norms. Overall, the revenue trends underscore Akzo Nobel’s ability to capitalize on market demand while effectively managing operational expenses.
Profitability and Efficiency Metrics
Akzo Nobel India reported a net profit of ₹1,990 Cr, translating to a remarkable return on equity (ROE) of 32.2% and a return on capital employed (ROCE) of 41.7%. These metrics highlight the company’s effectiveness in generating returns from its equity and capital investments. The operating profit figures reveal resilience, with operating profits recorded at ₹642 Cr for the fiscal year 2025, alongside an operating profit margin (OPM) consistently hovering around 16%. The interest coverage ratio (ICR) stood at an impressive 68.28x, indicating robust earnings relative to interest obligations, which enhances financial stability. However, the net profit margin of 10.49% for FY 2025 suggests room for improvement compared to sector benchmarks, which typically range higher. Overall, Akzo Nobel’s profitability and efficiency metrics illustrate a strong operational framework, albeit with potential challenges in maximizing profit margins.
Balance Sheet Strength and Financial Ratios
As of September 2025, Akzo Nobel India reported reserves of ₹2,208 Cr and borrowings of ₹71 Cr, reflecting a solid balance sheet with minimal leverage. The company’s debt-to-equity ratio remains low, showcasing prudent financial management and a strong capacity for self-financing. The book value per share stood at ₹292.09, indicating a healthy asset base relative to its market valuation, with a price-to-book value (P/BV) ratio of 12.32x. This high P/BV suggests that the market has high expectations for future growth, yet it may also indicate overvaluation compared to typical sector averages. Additionally, the current ratio of 1.38x indicates adequate liquidity to meet short-term obligations. While the balance sheet exhibits strength through low debt levels and substantial reserves, the elevated P/BV ratio may pose a risk if growth expectations are not met in future periods.
Shareholding Pattern and Investor Confidence
Akzo Nobel India’s shareholding structure reflects a strong promoter presence, with promoters holding 69.76% of the equity as of September 2025. This significant ownership suggests a high level of confidence from the founding entities in the company’s strategic direction and operational performance. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have increased their stakes, with FIIs at 7.97% and DIIs at 13.77%, indicating growing institutional interest. The number of shareholders rose to 48,226, demonstrating increasing retail participation, which often correlates with enhanced market sentiment. However, the gradual decline in promoter holding from 74.76% in December 2022 to the current level could raise concerns about potential dilution and its impact on investor confidence. Overall, the shareholding pattern indicates a robust base of support, but the changes in promoter equity may warrant further scrutiny.
Outlook, Risks, and Final Insight
The outlook for Akzo Nobel India appears positive, supported by strong financial performance and effective operational strategies. The company’s impressive ROE and ROCE suggest a solid capacity for generating shareholder value. However, risks remain, particularly in managing profit margins, which have shown variability. Additionally, the elevated P/BV ratio may expose the company to valuation corrections if growth targets are not met. Furthermore, fluctuations in raw material costs and competitive pressures in the paints industry could impact profitability. In scenarios where operational efficiencies improve and cost management strategies are effectively implemented, Akzo Nobel could enhance its profit margins and sustain growth. Conversely, failure to navigate market challenges may hinder performance and affect investor sentiment. Thus, while Akzo Nobel presents a strong case for investment, careful monitoring of market dynamics and internal efficiencies will be crucial for sustained success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Sirca Paints India Ltd | 2,612 Cr. | 460 | 539/231 | 45.1 | 78.0 | 0.33 % | 20.0 % | 14.9 % | 10.0 |
| Shalimar Paints Ltd | 501 Cr. | 59.9 | 144/54.1 | 34.0 | 0.00 % | 12.8 % | 22.6 % | 2.00 | |
| Kansai Nerolac Paints Ltd | 18,360 Cr. | 227 | 275/218 | 28.2 | 80.1 | 1.10 % | 13.0 % | 10.4 % | 1.00 |
| Berger Paints India Ltd | 58,823 Cr. | 504 | 605/458 | 53.2 | 53.9 | 0.75 % | 24.9 % | 20.3 % | 1.00 |
| Akzo Nobel India Ltd | 13,382 Cr. | 2,939 | 3,916/2,910 | 34.3 | 495 | 3.40 % | 41.7 % | 32.2 % | 10.0 |
| Industry Average | 58,836.00 Cr | 1,148.98 | 45.06 | 157.50 | 1.08% | 23.02% | 20.17% | 4.17 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 926 | 987 | 951 | 999 | 956 | 1,033 | 973 | 1,036 | 982 | 1,050 | 1,022 | 995 | 835 |
| Expenses | 820 | 844 | 797 | 837 | 814 | 866 | 812 | 867 | 836 | 884 | 863 | 861 | 724 |
| Operating Profit | 106 | 143 | 155 | 162 | 142 | 166 | 162 | 169 | 146 | 167 | 159 | 134 | 111 |
| OPM % | 11% | 14% | 16% | 16% | 15% | 16% | 17% | 16% | 15% | 16% | 16% | 14% | 13% |
| Other Income | 5 | 12 | 6 | 8 | 9 | 8 | 10 | 10 | 9 | 6 | 3 | 9 | 1,882 |
| Interest | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 3 | 2 |
| Depreciation | 20 | 21 | 22 | 19 | 21 | 20 | 22 | 22 | 22 | 23 | 22 | 18 | 18 |
| Profit before tax | 88 | 132 | 133 | 148 | 127 | 152 | 147 | 154 | 132 | 146 | 137 | 122 | 1,972 |
| Tax % | 26% | 26% | 28% | 26% | 26% | 25% | 26% | 26% | 26% | 26% | 22% | 26% | 15% |
| Net Profit | 65 | 97 | 95 | 110 | 94 | 114 | 109 | 115 | 98 | 109 | 108 | 91 | 1,683 |
| EPS in Rs | 14.36 | 21.39 | 20.95 | 24.13 | 20.68 | 24.99 | 23.89 | 25.16 | 21.50 | 23.85 | 23.61 | 19.98 | 369.50 |
Last Updated: January 2, 2026, 2:03 pm
Below is a detailed analysis of the quarterly data for Akzo Nobel India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 835.00 Cr.. The value appears to be declining and may need further review. It has decreased from 995.00 Cr. (Jun 2025) to 835.00 Cr., marking a decrease of 160.00 Cr..
- For Expenses, as of Sep 2025, the value is 724.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 861.00 Cr. (Jun 2025) to 724.00 Cr., marking a decrease of 137.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 111.00 Cr.. The value appears to be declining and may need further review. It has decreased from 134.00 Cr. (Jun 2025) to 111.00 Cr., marking a decrease of 23.00 Cr..
- For OPM %, as of Sep 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Jun 2025) to 13.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 1,882.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Jun 2025) to 1,882.00 Cr., marking an increase of 1,873.00 Cr..
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Jun 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 18.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1,972.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Jun 2025) to 1,972.00 Cr., marking an increase of 1,850.00 Cr..
- For Tax %, as of Sep 2025, the value is 15.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 15.00%, marking a decrease of 11.00%.
- For Net Profit, as of Sep 2025, the value is 1,683.00 Cr.. The value appears strong and on an upward trend. It has increased from 91.00 Cr. (Jun 2025) to 1,683.00 Cr., marking an increase of 1,592.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 369.50. The value appears strong and on an upward trend. It has increased from 19.98 (Jun 2025) to 369.50, marking an increase of 349.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,332 | 2,442 | 2,640 | 2,572 | 2,719 | 2,918 | 2,662 | 2,421 | 3,149 | 3,802 | 3,962 | 4,091 | 3,903 |
| Expenses | 2,141 | 2,181 | 2,380 | 2,244 | 2,420 | 2,576 | 2,291 | 2,078 | 2,714 | 3,276 | 3,328 | 3,449 | 3,332 |
| Operating Profit | 192 | 261 | 260 | 329 | 300 | 342 | 370 | 343 | 434 | 526 | 633 | 642 | 571 |
| OPM % | 8% | 11% | 10% | 13% | 11% | 12% | 14% | 14% | 14% | 14% | 16% | 16% | 15% |
| Other Income | 57 | 68 | 110 | 65 | 240 | 43 | 41 | 21 | 23 | 26 | 35 | 27 | 1,900 |
| Interest | 2 | 2 | 2 | 3 | 4 | 4 | 9 | 10 | 14 | 14 | 12 | 10 | 11 |
| Depreciation | 44 | 53 | 54 | 54 | 58 | 65 | 79 | 76 | 76 | 82 | 82 | 89 | 82 |
| Profit before tax | 203 | 275 | 314 | 337 | 478 | 316 | 323 | 278 | 367 | 456 | 573 | 570 | 2,378 |
| Tax % | 26% | 32% | 32% | 27% | 16% | 33% | 27% | 25% | 21% | 26% | 26% | 25% | |
| Net Profit | 150 | 186 | 214 | 247 | 401 | 211 | 237 | 208 | 290 | 335 | 427 | 429 | 1,990 |
| EPS in Rs | 32.19 | 39.93 | 45.91 | 52.94 | 85.85 | 46.33 | 52.13 | 45.59 | 63.68 | 73.58 | 93.70 | 94.11 | 436.94 |
| Dividend Payout % | 233% | 50% | 153% | 42% | 26% | 52% | 27% | 110% | 118% | 88% | 80% | 106% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 24.00% | 15.05% | 15.42% | 62.35% | -47.38% | 12.32% | -12.24% | 39.42% | 15.52% | 27.46% | 0.47% |
| Change in YoY Net Profit Growth (%) | 0.00% | -8.95% | 0.37% | 46.93% | -109.73% | 59.70% | -24.56% | 51.66% | -23.91% | 11.95% | -26.99% |
Akzo Nobel India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 21% |
| 1 Year: | -4% |
| Return on Equity | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 26% |
| 3 Years: | 30% |
| Last Year: | 32% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: December 4, 2025, 12:55 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 47 | 47 | 47 | 47 | 47 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
| Reserves | 801 | 873 | 1,116 | 962 | 1,244 | 1,090 | 1,192 | 1,242 | 1,213 | 1,270 | 1,284 | 1,283 | 2,208 |
| Borrowings | 0 | 0 | 3 | 3 | 3 | 3 | 64 | 64 | 70 | 70 | 60 | 62 | 71 |
| Other Liabilities | 1,191 | 879 | 878 | 872 | 938 | 959 | 1,024 | 1,178 | 1,261 | 1,354 | 1,513 | 1,511 | 1,315 |
| Total Liabilities | 2,039 | 1,799 | 2,043 | 1,884 | 2,231 | 2,097 | 2,325 | 2,529 | 2,590 | 2,739 | 2,903 | 2,902 | 3,640 |
| Fixed Assets | 502 | 516 | 523 | 519 | 539 | 530 | 574 | 543 | 520 | 511 | 526 | 481 | 1,580 |
| CWIP | 31 | 12 | 9 | 23 | 27 | 17 | 16 | 16 | 42 | 73 | 119 | 67 | 74 |
| Investments | 629 | 394 | 600 | 336 | 573 | 377 | 84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 877 | 876 | 911 | 1,006 | 1,092 | 1,173 | 1,652 | 1,969 | 2,029 | 2,156 | 2,258 | 2,354 | 1,987 |
| Total Assets | 2,039 | 1,799 | 2,043 | 1,884 | 2,231 | 2,097 | 2,325 | 2,529 | 2,590 | 2,739 | 2,903 | 2,902 | 3,640 |
Below is a detailed analysis of the balance sheet data for Akzo Nobel India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 46.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 46.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,208.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,283.00 Cr. (Mar 2025) to 2,208.00 Cr., marking an increase of 925.00 Cr..
- For Borrowings, as of Sep 2025, the value is 71.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 62.00 Cr. (Mar 2025) to 71.00 Cr., marking an increase of 9.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,315.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,511.00 Cr. (Mar 2025) to 1,315.00 Cr., marking a decrease of 196.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,640.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,902.00 Cr. (Mar 2025) to 3,640.00 Cr., marking an increase of 738.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,580.00 Cr.. The value appears strong and on an upward trend. It has increased from 481.00 Cr. (Mar 2025) to 1,580.00 Cr., marking an increase of 1,099.00 Cr..
- For CWIP, as of Sep 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 74.00 Cr., marking an increase of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,987.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,354.00 Cr. (Mar 2025) to 1,987.00 Cr., marking a decrease of 367.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,640.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,902.00 Cr. (Mar 2025) to 3,640.00 Cr., marking an increase of 738.00 Cr..
Notably, the Reserves (2,208.00 Cr.) exceed the Borrowings (71.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 192.00 | 261.00 | 257.00 | 326.00 | 297.00 | 339.00 | 306.00 | 279.00 | 364.00 | 456.00 | 573.00 | 580.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 48 | 42 | 49 | 58 | 53 | 56 | 54 | 62 | 57 | 53 | 53 | 52 |
| Inventory Days | 86 | 95 | 89 | 107 | 84 | 85 | 107 | 135 | 129 | 95 | 100 | 95 |
| Days Payable | 130 | 119 | 145 | 164 | 159 | 131 | 171 | 220 | 164 | 138 | 164 | 151 |
| Cash Conversion Cycle | 4 | 17 | -7 | 1 | -22 | 9 | -10 | -23 | 22 | 11 | -10 | -3 |
| Working Capital Days | -62 | -12 | -59 | 15 | 10 | 20 | -3 | -14 | 14 | 4 | -2 | 22 |
| ROCE % | 16% | 25% | 26% | 27% | 40% | 24% | 27% | 22% | 28% | 35% | 42% | 42% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Multi Cap Fund | 960,885 | 0.64 | 318.13 | 814,894 | 2025-12-15 00:06:32 | 17.92% |
| HDFC Small Cap Fund | 847,275 | 0.74 | 280.52 | 445,231 | 2025-12-15 00:06:32 | 90.3% |
| ICICI Prudential Value Fund | 706,501 | 0.39 | 233.91 | N/A | N/A | N/A |
| Aditya Birla Sun Life Large Cap Fund | 520,550 | 0.55 | 172.34 | 706,250 | 2025-12-15 00:06:32 | -26.29% |
| HDFC Childrens Fund | 463,675 | 1.44 | 153.51 | N/A | N/A | N/A |
| HDFC Multi Cap Fund | 400,471 | 0.67 | 132.59 | 325,471 | 2025-12-15 00:06:32 | 23.04% |
| Tata Small Cap Fund | 287,484 | 0.83 | 95.18 | N/A | N/A | N/A |
| ICICI Prudential Equity Savings Fund | 228,483 | 0.43 | 75.65 | N/A | N/A | N/A |
| Tata Large & Mid Cap Fund | 181,800 | 0.69 | 60.19 | N/A | N/A | N/A |
| HDFC Hybrid Equity Fund | 177,752 | 0.24 | 58.85 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 94.31 | 93.68 | 73.58 | 63.70 | 45.60 |
| Diluted EPS (Rs.) | 94.31 | 93.68 | 73.58 | 63.70 | 45.60 |
| Cash EPS (Rs.) | 114.04 | 111.85 | 91.78 | 80.44 | 62.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 292.09 | 292.02 | 289.03 | 276.55 | 282.88 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 292.35 | 292.29 | 289.30 | 276.81 | 283.14 |
| Revenue From Operations / Share (Rs.) | 899.16 | 870.68 | 835.63 | 692.00 | 532.17 |
| PBDIT / Share (Rs.) | 147.05 | 146.77 | 121.43 | 100.04 | 80.00 |
| PBIT / Share (Rs.) | 127.41 | 128.68 | 103.30 | 83.36 | 63.41 |
| PBT / Share (Rs.) | 125.25 | 125.93 | 100.20 | 80.61 | 61.14 |
| Net Profit / Share (Rs.) | 94.39 | 93.76 | 73.65 | 63.76 | 45.63 |
| NP After MI And SOA / Share (Rs.) | 94.39 | 93.76 | 73.65 | 63.76 | 45.63 |
| PBDIT Margin (%) | 16.35 | 16.85 | 14.53 | 14.45 | 15.03 |
| PBIT Margin (%) | 14.16 | 14.77 | 12.36 | 12.04 | 11.91 |
| PBT Margin (%) | 13.92 | 14.46 | 11.99 | 11.64 | 11.48 |
| Net Profit Margin (%) | 10.49 | 10.76 | 8.81 | 9.21 | 8.57 |
| NP After MI And SOA Margin (%) | 10.49 | 10.76 | 8.81 | 9.21 | 8.57 |
| Return on Networth / Equity (%) | 32.31 | 32.10 | 25.48 | 23.05 | 16.12 |
| Return on Capital Employeed (%) | 39.88 | 39.55 | 31.82 | 26.94 | 20.05 |
| Return On Assets (%) | 14.79 | 14.69 | 12.22 | 11.19 | 8.20 |
| Asset Turnover Ratio (%) | 1.41 | 1.40 | 1.43 | 1.23 | 0.99 |
| Current Ratio (X) | 1.38 | 1.35 | 1.48 | 1.49 | 1.60 |
| Quick Ratio (X) | 0.96 | 0.92 | 1.00 | 0.92 | 1.15 |
| Inventory Turnover Ratio (X) | 6.73 | 3.32 | 3.30 | 3.08 | 2.56 |
| Dividend Payout Ratio (NP) (%) | 100.72 | 96.08 | 81.52 | 109.89 | 74.56 |
| Dividend Payout Ratio (CP) (%) | 83.36 | 80.54 | 65.42 | 87.10 | 54.68 |
| Earning Retention Ratio (%) | -0.72 | 3.92 | 18.48 | -9.89 | 25.44 |
| Cash Earning Retention Ratio (%) | 16.64 | 19.46 | 34.58 | 12.90 | 45.32 |
| Interest Coverage Ratio (X) | 68.28 | 53.42 | 39.18 | 31.39 | 35.34 |
| Interest Coverage Ratio (Post Tax) (X) | 44.83 | 35.13 | 24.77 | 20.87 | 21.16 |
| Enterprise Value (Cr.) | 16078.36 | 10323.76 | 9851.79 | 8249.97 | 9768.88 |
| EV / Net Operating Revenue (X) | 3.93 | 2.61 | 2.59 | 2.62 | 4.03 |
| EV / EBITDA (X) | 24.03 | 15.46 | 17.83 | 18.12 | 26.84 |
| MarketCap / Net Operating Revenue (X) | 4.00 | 2.74 | 2.74 | 2.77 | 4.34 |
| Retention Ratios (%) | -0.72 | 3.91 | 18.47 | -9.89 | 25.43 |
| Price / BV (X) | 12.32 | 8.16 | 7.92 | 6.92 | 8.16 |
| Price / Net Operating Revenue (X) | 4.00 | 2.74 | 2.74 | 2.77 | 4.34 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 |
After reviewing the key financial ratios for Akzo Nobel India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 94.31. This value is within the healthy range. It has increased from 93.68 (Mar 24) to 94.31, marking an increase of 0.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 94.31. This value is within the healthy range. It has increased from 93.68 (Mar 24) to 94.31, marking an increase of 0.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 114.04. This value is within the healthy range. It has increased from 111.85 (Mar 24) to 114.04, marking an increase of 2.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 292.09. It has increased from 292.02 (Mar 24) to 292.09, marking an increase of 0.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 292.35. It has increased from 292.29 (Mar 24) to 292.35, marking an increase of 0.06.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 899.16. It has increased from 870.68 (Mar 24) to 899.16, marking an increase of 28.48.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 147.05. This value is within the healthy range. It has increased from 146.77 (Mar 24) to 147.05, marking an increase of 0.28.
- For PBIT / Share (Rs.), as of Mar 25, the value is 127.41. This value is within the healthy range. It has decreased from 128.68 (Mar 24) to 127.41, marking a decrease of 1.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 125.25. This value is within the healthy range. It has decreased from 125.93 (Mar 24) to 125.25, marking a decrease of 0.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 94.39. This value is within the healthy range. It has increased from 93.76 (Mar 24) to 94.39, marking an increase of 0.63.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 94.39. This value is within the healthy range. It has increased from 93.76 (Mar 24) to 94.39, marking an increase of 0.63.
- For PBDIT Margin (%), as of Mar 25, the value is 16.35. This value is within the healthy range. It has decreased from 16.85 (Mar 24) to 16.35, marking a decrease of 0.50.
- For PBIT Margin (%), as of Mar 25, the value is 14.16. This value is within the healthy range. It has decreased from 14.77 (Mar 24) to 14.16, marking a decrease of 0.61.
- For PBT Margin (%), as of Mar 25, the value is 13.92. This value is within the healthy range. It has decreased from 14.46 (Mar 24) to 13.92, marking a decrease of 0.54.
- For Net Profit Margin (%), as of Mar 25, the value is 10.49. This value exceeds the healthy maximum of 10. It has decreased from 10.76 (Mar 24) to 10.49, marking a decrease of 0.27.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.49. This value is within the healthy range. It has decreased from 10.76 (Mar 24) to 10.49, marking a decrease of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 32.31. This value is within the healthy range. It has increased from 32.10 (Mar 24) to 32.31, marking an increase of 0.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is 39.88. This value is within the healthy range. It has increased from 39.55 (Mar 24) to 39.88, marking an increase of 0.33.
- For Return On Assets (%), as of Mar 25, the value is 14.79. This value is within the healthy range. It has increased from 14.69 (Mar 24) to 14.79, marking an increase of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.41. It has increased from 1.40 (Mar 24) to 1.41, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 1.5. It has increased from 1.35 (Mar 24) to 1.38, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.92 (Mar 24) to 0.96, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.73. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 6.73, marking an increase of 3.41.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 100.72. This value exceeds the healthy maximum of 50. It has increased from 96.08 (Mar 24) to 100.72, marking an increase of 4.64.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 83.36. This value exceeds the healthy maximum of 50. It has increased from 80.54 (Mar 24) to 83.36, marking an increase of 2.82.
- For Earning Retention Ratio (%), as of Mar 25, the value is -0.72. This value is below the healthy minimum of 40. It has decreased from 3.92 (Mar 24) to -0.72, marking a decrease of 4.64.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 16.64. This value is below the healthy minimum of 40. It has decreased from 19.46 (Mar 24) to 16.64, marking a decrease of 2.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 68.28. This value is within the healthy range. It has increased from 53.42 (Mar 24) to 68.28, marking an increase of 14.86.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 44.83. This value is within the healthy range. It has increased from 35.13 (Mar 24) to 44.83, marking an increase of 9.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 16,078.36. It has increased from 10,323.76 (Mar 24) to 16,078.36, marking an increase of 5,754.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.93. This value exceeds the healthy maximum of 3. It has increased from 2.61 (Mar 24) to 3.93, marking an increase of 1.32.
- For EV / EBITDA (X), as of Mar 25, the value is 24.03. This value exceeds the healthy maximum of 15. It has increased from 15.46 (Mar 24) to 24.03, marking an increase of 8.57.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has increased from 2.74 (Mar 24) to 4.00, marking an increase of 1.26.
- For Retention Ratios (%), as of Mar 25, the value is -0.72. This value is below the healthy minimum of 30. It has decreased from 3.91 (Mar 24) to -0.72, marking a decrease of 4.63.
- For Price / BV (X), as of Mar 25, the value is 12.32. This value exceeds the healthy maximum of 3. It has increased from 8.16 (Mar 24) to 12.32, marking an increase of 4.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has increased from 2.74 (Mar 24) to 4.00, marking an increase of 1.26.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Akzo Nobel India Ltd:
- Net Profit Margin: 10.49%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 39.88% (Industry Average ROCE: 23.02%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 32.31% (Industry Average ROE: 20.17%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 44.83
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.3 (Industry average Stock P/E: 45.06)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.49%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Paints/Varnishes | 801A, South City Business Park, 770, Anandapur, Kolkata West Bengal 700107 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajiv Rajgopal | Chairman & Managing Director |
| Mr. Krishna Rallapalli | WholeTime Director & CFO |
| Mr. Rohit G Totla | Whole Time Director |
| Mr. Hemant Sahai | Independent Director |
| Mr. Anil Chaudhry | Independent Director |
| Ms. Namrata Kaul | Independent Director |
FAQ
What is the intrinsic value of Akzo Nobel India Ltd?
Akzo Nobel India Ltd's intrinsic value (as of 25 January 2026) is ₹6647.37 which is 126.18% higher the current market price of ₹2,939.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹13,382 Cr. market cap, FY2025-2026 high/low of ₹3,916/2,910, reserves of ₹2,208 Cr, and liabilities of ₹3,640 Cr.
What is the Market Cap of Akzo Nobel India Ltd?
The Market Cap of Akzo Nobel India Ltd is 13,382 Cr..
What is the current Stock Price of Akzo Nobel India Ltd as on 25 January 2026?
The current stock price of Akzo Nobel India Ltd as on 25 January 2026 is ₹2,939.
What is the High / Low of Akzo Nobel India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Akzo Nobel India Ltd stocks is ₹3,916/2,910.
What is the Stock P/E of Akzo Nobel India Ltd?
The Stock P/E of Akzo Nobel India Ltd is 34.3.
What is the Book Value of Akzo Nobel India Ltd?
The Book Value of Akzo Nobel India Ltd is 495.
What is the Dividend Yield of Akzo Nobel India Ltd?
The Dividend Yield of Akzo Nobel India Ltd is 3.40 %.
What is the ROCE of Akzo Nobel India Ltd?
The ROCE of Akzo Nobel India Ltd is 41.7 %.
What is the ROE of Akzo Nobel India Ltd?
The ROE of Akzo Nobel India Ltd is 32.2 %.
What is the Face Value of Akzo Nobel India Ltd?
The Face Value of Akzo Nobel India Ltd is 10.0.